Molecular Templates, Inc. entered into a worldwide strategic research collaboration with Bristol Myers Squibb to discover and develop multiple therapies for specific oncology targets. The collaboration aims to discover new molecules utilizing MTEM’s next-gen engineered toxin body (ETB) platform. ETBs represent a new class of targeted therapeutics that act through differentiated mechanisms of actions including the ability to force receptor internalization, deliver therapeutic payloads, and direct...